Author

K. Cohen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Scientific Communication & Education· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:cell signaling & trafficking· 1 Assay:ChIP-seq· 1 Research Focus:database / resource· 1 Research Focus:ecology & biodiversity· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. B. Stuart· 1 shared A. Finzi· 1 shared A. K. Hahs· 1 shared A. MacCamey· 1 shared A. McGuire· 1 shared A. Mezzetti· 1 shared A. Shaw· 1 shared A. Siam· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. B. Stuart

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The City Nature Challenge - A global citizen science phenomenon contributing to biodiversity knowledge and informing local government practices

E. Palma, L. Mata, K. Cohen, D. Evans, B. Gandy, N. Gaskell, H. Hatchman, A. Mezzetti, D. Neumann, J. O'Keefe, A. Shaw, M. Wells, L. Williams, A. K. Hahs

The paper evaluates the City Nature Challenge's contribution to biodiversity knowledge and local government practices through a case study and framework development.

bioRxiv · Nov 14, 2022Scientific Communication & Education

Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects

M. Jennewein, A. MacCamey, N. Akins, J. Feng, L. Homad, N. Hurlburt, E. Seydoux, Y.-H. Wang, A. B. Stuart, V. V. Edara, K. Floyd, A. Vanderheiden, J. R. Mascola, N. Doria-Rose, L. Wang, , L. Stamatatos

The paper isolates and characterizes cross-neutralizing antibodies from COVID-19 patients, identifying antibodies that neutralize both SARS-CoV-1 and SARS-CoV-2, including variants.

bioRxiv · Mar 23, 2021 · PreprintImmunology

VEGFA's distal enhancer regulates its alternative splicing in CML

S. Dahan, K. Cohen, M. Dentata, E. Engal, A. Siam, G. Kay, Y. Drier, S. Elias, M. Salton

This study shows that the VEGFA enhancer regulates its alternative splicing in CML by enhancing RNA polymerase II elongation via CCNT2.

bioRxiv · Jan 9, 2021Cancer Biology